Novel Compound Has Promise for Treatment of Huntington’s Disease

Mass. General-led study identifies molecular compound with two neuroprotective activities. Please join us in congratulating HD-CARE Scientific Advisory Board members, Dr. Malcolm Casale and Dr. Leslie Thompson and Dr. Ryan Lim on the publication of the Mass General News Release.


Dr. Malcolm Casale;  Dr. Leslie Thompson;  and Dr. Ryan Lim

Originally posted July, 2016

Categories: ResearchTags: , , ,